Opaleye Management Inc.
SEC insider (Form 3/4/5 filer). CIK 0001595855. 10% Owner at Alpha Cognition Inc. (ACOG) and 7 other issuers. 240 reported Form 4/5 transactions since Sep 2024; latest on Oct 26, 2026. Located in BOSTON, MA.
Companies Opaleye Management Inc. has filed insider reports for
- Alpha Cognition Inc. (ACOG): 10% Owner
- Grace Therapeutics, Inc. (GRCE): 10% Owner
- Sol-Gel Technologies Ltd. (SLGL): 10% Owner
- Eton Pharmaceuticals, Inc. (ETON): 10% Owner
- SANUWAVE Health, Inc. (SNWV): 10% Owner
- HARROW, INC. (HROW): 10% Owner
- CODEXIS, INC. (CDXS): 10% Owner
- Protara Therapeutics, Inc. (TARA): 10% Owner
Opaleye Management Inc.
CIK: 0001595855
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (240 total)
- Oct 26, 2026GRCE
Grace Therapeutics, Inc.
PurchaseIndirect66.4K shares at avg. $1.77$117K - Oct 23, 2026ACOG
Alpha Cognition Inc.
PurchaseIndirect15K shares at avg. $8.23$123K - Oct 22, 2026GRCE
Grace Therapeutics, Inc.
PurchaseIndirect21.4K shares at avg. $1.93$41K - Oct 22, 2026ACOG
Alpha Cognition Inc.
PurchaseIndirect17.1K shares at avg. $8.33$143K - Oct 19, 2026GRCE
Grace Therapeutics, Inc.
PurchaseIndirect4.3K shares at avg. $1.88$8K - Oct 16, 2026ACOG
Alpha Cognition Inc.
PurchaseIndirect14.3K shares at avg. $8.23$118K - Oct 16, 2026GRCE
Grace Therapeutics, Inc.
PurchaseIndirect36.3K shares at avg. $1.89$69K - Oct 15, 2026ACOG
Alpha Cognition Inc.
PurchaseIndirect22.7K shares at avg. $8.43$191K - Oct 15, 2026GRCE
Grace Therapeutics, Inc.
PurchaseIndirect23.5K shares at avg. $1.95$46K - Oct 14, 2026GRCE
Grace Therapeutics, Inc.
PurchaseIndirect11.2K shares at avg. $1.93$22K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 26, 2026 |  GRCE Grace Therapeutics, Inc. | Purchase | 66,411 | $1.77 | $117,408 | Indirect |
| Oct 23, 2026 |  ACOG Alpha Cognition Inc. | Purchase | 14,973 | $8.23 | $123,294 | Indirect |
| Oct 22, 2026 | GRCE Grace Therapeutics, Inc. | Purchase | 21,390 | $1.93 | $41,193 | Indirect |
| Oct 22, 2026 | ACOG Alpha Cognition Inc. | Purchase | 17,117 | $8.33 | $142,526 | Indirect |
| Oct 19, 2026 | GRCE Grace Therapeutics, Inc. | Purchase | 4,256 | $1.88 | $8,001 | Indirect |
| Oct 16, 2026 | ACOG Alpha Cognition Inc. | Purchase | 14,283 | $8.23 | $117,602 | Indirect |
| Oct 16, 2026 | GRCE Grace Therapeutics, Inc. | Purchase | 36,347 | $1.89 | $68,758 | Indirect |
| Oct 15, 2026 | ACOG Alpha Cognition Inc. | Purchase | 22,657 | $8.43 | $190,974 | Indirect |
| Oct 15, 2026 | GRCE Grace Therapeutics, Inc. | Purchase | 23,485 | $1.95 | $45,685 | Indirect |
| Oct 14, 2026 | GRCE Grace Therapeutics, Inc. | Purchase | 11,233 | $1.93 | $21,735 | Indirect |
1-10 of 240 transactions